ADAM17 Monoklonaler Antikörper
ADAM17 Monoklonal Antikörper für WB, Cytometric bead array, Indirect ELISA
Wirt / Isotyp
Maus / IgG1
Getestete Reaktivität
human, Maus
Anwendung
WB, Cytometric bead array, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
2F4C2
Kat-Nr. : 68725-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
68725-1-PBS bindet in WB, Cytometric bead array, Indirect ELISA ADAM17 und zeigt Reaktivität mit human, Maus
| Getestete Reaktivität | human, Maus |
| Wirt / Isotyp | Maus / IgG1 |
| Klonalität | Monoklonal |
| Typ | Antikörper |
| Immunogen | ADAM17 fusion protein Ag34022 |
| Vollständiger Name | ADAM metallopeptidase domain 17 |
| Berechnetes Molekulargewicht | 824 aa, 93 kDa |
| Beobachtetes Molekulargewicht | 90-110 kDa |
| GenBank-Zugangsnummer | BC136783 |
| Gene symbol | ADAM17 |
| Gene ID (NCBI) | 6868 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-G-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
The ADAMs (A Disintegrin And Metalloprotease) are multidomain transmembrane proteins. One of the first ADAMs implicated in membrane shedding is ADAM-17, which is shown to release the active form of tumor necrosis factor (TNF)-a from its precursor (PMID:18238782). ADAM17 is also named as CSVP, TACE. The full length protein has 9 glycosylation sites, a signal peptide, propeptide and 2 isoforms produced by alternative splicing.The 120-kDa form of ADAM-17 is expressed more frequently and at higher levels in primary breast carcinomas compared with normal breast tissue(PMID:17438092).





